Previous research has demonstrated that CaN-NFAT plays a significant role in the development of cardiac hypertrophy and that overactivation of PPAR-α might inhibit the nuclear translocation of NFAT-1 from the cytoplasm to the nucleus [39, 51]. Here, NFATC2 is linked to cardiac hypertrophy.